Eli Lilly shares saw a mild pullback of -1.21% during the regular session, trading slightly lower in after-hours around $1,040, as a MarketWatch/Dow Jones article highlighted an extreme rotation of capital from tech into the healthcare sector.
- The analysis suggests that Eli Lilly has "crushed" Nvidia in recent weeks and year-to-date, framing the current mild decline as part of this broader sector shift rather than a reaction to company-specific news.
- Since the tech sector peak on October 29, Eli Lilly has climbed approximately 30%, contrasting sharply with Nvidia's loss of roughly 14% over the same period.